Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 10, 2011, Pages 737-742

  Hasu, Mirela ^a   Thabet, Mohamed ^a   Tam, Nancy ^a   Whitman, Stewart C ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Atherosclerosis; Bone marrow transplant; Inflammation; Innate immunity; Lipoproteins; Low density lipoprotein receptor; Toll like receptor 2

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TOLL LIKE RECEPTOR 2; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW CELL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; FEMALE; GENOTYPE; INNATE IMMUNITY; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; TLR2 GENE;

ANIMALS; AORTA; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET, ATHEROGENIC; FEMALE; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; TOLL-LIKE RECEPTOR 2;

EID: 80053071991     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-071     Document Type: Article

References (13)

1. Akira, S., and Takeda, K. 2004. Toll-like receptor signaling. Nat. Rev. Immunol. 4(7): 499-511. doi:10.1038/nri1391. PMID:15229469.
2. Boisvert, W.A., Spangenberg, J., and Curtiss, L.K. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96(2): 1118-1124. doi:10.1172/JCI118098. PMID:7635947.
3. Curtiss, L.K., and Tobias, P.S. 2009. Emerging role of Toll-like receptors in atherosclerosis. J. Lipid Res. 50(Suppl.): S340-S345. doi:10.1194/jlr.R800056-JLR200. PMID:18980945.
4. Dansky, H.M., Charlton, S.A., Harper, M.M., and Smith, J.D. 1997. T and B lymphocytes play a minor sole in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. U.S.A. 94(9): 4642-4646. doi:10.1073/pnas.94.9.4642. PMID:9114044.
5. Erridge, C. 2008. The roles of pathogen-associated molecular patterns in atherosclerosis. Trends Cardiovasc. Med. 18(2): 52-56. doi:10.1016/j.tcm.2007.12.003. PMID:18308195.
6. Linton, M.F., Atkinson, J.B., and Fazio, S. 1995. Prevention of athersclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science, 267(5200): 1034-1037. doi:10.1126/science.7863332. PMID:7863332.
7. -/- mice. Radiat. Res. 175(5): 665-676. doi:10.1667/RR2176.1. PMID:21375359.
8. Mullick, A.E., Tobias, P.S., and Curtiss, L.K. 2005. Modulation of atherosclerosis inmice by Toll-like receptor 2. J. Clin. Invest. 115(11): 3149-3156. doi:10.1172/JCI25482. PMID:16211093.
9. Mullick, A.E., Soldau, K., Kiosses, W.B., Bell, T.A., III, Tobias, P.S., and Curtiss, L.K. 2008. Increased endothelial expression of Tolllike receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J. Exp. Med. 205(2): 373-383. doi:10.1084/jem.20071096. PMID:18250194.
10. Song, L., Leung, C., and Schindler, C. 2001. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108(2): 251-259. PMID:11457878.
11. Takeda, K., and Akira, S. 2004. Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 34(2): 73-82. doi:10.1016/j.jdermsci. 2003.10.002. PMID:15033189.
12. -/- mice. J. Interferon Cytokine Res. 22(6): 661-670. doi:10.1089/10799900260100141. PMID:12162876.
13. Whitman, S.C., Rateri, D.L., Szilvassy, S.J., Yokoyama, W., and Daugherty, A. 2004. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler. Thromb. Vasc. Biol. 24(6): 1049-1054. doi:10.1161/01.ATV.0000124923.95545.2c. PMID:14988092.